October 19, 2017

Biotechnology, Life Sciences, Food and Drug Law News

Home > Practice-groups > Biotech & Cleantech
Subscribe to Biotech, Food & Drug

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals.  Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market.  Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date Title Organization
19
Oct
 EPA Publishes SNUR for MWCNTs (Generic) Bergeson & Campbell, P.C.
19
Oct
 FDA Releases Guidance Documents Concerning Animal Food CGMPs and the FSMA “Solely Engaged” Exemptions Keller and Heckman LLP
18
Oct
 New Jersey October 2, 2017 Healthcare Regulatory Developments Giordano, Halleran & Ciesla, P.C.
18
Oct
 TTB Reopens Comment Period for Three Notices of Proposed Rulemaking McDermott Will & Emery
18
Oct
 Philly Sweetened Beverage Tax Under Fire Keller and Heckman LLP
18
Oct
 FDA Finalizes Guidance on Medical Product Classification Covington & Burling LLP
18
Oct
 Australia Classifies E-Cigarettes as Dangerous Stark & Stark
17
Oct
 TTB Issues Guidance on Application of Consignment Sales Regulations to Freshness Dating and Returns from Retailers McDermott Will & Emery
17
Oct
 Recent Federal Developments - October 16, 2017: PPDC Meeting, FIFRA Scientific Advisory Panel, Management Of Pesticide Funds, Agricultural Biotechnology Education Bergeson & Campbell, P.C.
17
Oct
 GM Labeling Update: Ingredient Disclosure Debate Keller and Heckman LLP
16
Oct
 OECD Publishes Summary of Dossier on Silver Nanoparticles Bergeson & Campbell, P.C.
16
Oct
 Compulsory Licensing of Biopharmaceutical Inventions Sterne, Kessler, Goldstein & Fox P.L.L.C.
16
Oct
 CNN Investigates Expanding Use of Nuedexta in Nursing Homes Stark & Stark
16
Oct
 USDA Announces Comment Period on NCC Petition to Lift Poultry Line Speeds Keller and Heckman LLP
16
Oct
 New York State to Release Household Cleaning Product Disclosure Program; California Governor Brown Signs Cleaning Product Right to Know Act of 2017 (S.B. 258) Bergeson & Campbell, P.C.
13
Oct
 EU NanoSafety Cluster Will Hold Webinar on November 20 Bergeson & Campbell, P.C.
13
Oct
 USDA Announces $21 Million In Funding For Biobased Products Bergeson & Campbell, P.C.
13
Oct
 Spero Energy Receives SBIR Grant For Biobased Chelates Bergeson & Campbell, P.C.
13
Oct
 Massachusetts DPH Clears the Air for For-Profit Conversion of Medical Marijuana Dispensaries Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
13
Oct
 FDA Announces Meeting, Calls For Comments On FDA/USDA Agricultural Biotechnology Education And Outreach Initiative Bergeson & Campbell, P.C.

Pages

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

October 2017 OSHA 30/30
Wednesday, October 25, 2017
Anatomy of an ERD Hearing
Tuesday, November 7, 2017
TSCA 30/30 - November 8, 2017
Wednesday, November 8, 2017